(AIP) Arteris - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US04302A1043
AIP: Interconnect, IP, Silicon, Cache, Integration, Software
Arteris Inc. (NASDAQ: AIP) provides system intellectual property (IP) solutions for semiconductors, specializing in on-chip communications and IP block deployment for System-on-Chip (SoC) designs and chiplet-based systems. The companys portfolio includes Network-on-Chip (NoC) IP products such as FlexGen, FlexNoC, and FlexWay, which offer non-coherent NoC solutions, as well as Ncore, a cache-coherent NoC IP, and CodaCache, a last-level cache solution. Additionally, Arteris provides SoC integration automation software, including Magillem for connectivity and register management and CSRCompiler for IP and SoC software development. The company also offers professional services like training, design assistance, and consulting, along with licensing services for software and intellectual property, IP support, and on-site support. Arteris serves industries such as automotive, communications, enterprise computing, consumer electronics, and industrial sectors. Founded in 2003, the company is headquartered in Campbell, California. Web URL: https://www.arteris.com
Based on technical and fundamental data, here is a 3-month forecast: - Technical Outlook: AIP is currently trading below its 20-day SMA (9.73) and 50-day SMA (10.41), indicating bearish momentum. However, the 200-day SMA (8.47) suggests support near current levels. Average true range (ATR) of 0.70 indicates moderate volatility, with potential price fluctuations between 8.18 and 9.58 over the next quarter. - Fundamental Analysis: With a market cap of $380M and P/S ratio of 6.58, AIP is valued at a premium relative to its peers. The high P/B ratio of 56.04 reflects investor confidence in future growth, though profitability metrics remain absent. The companys focus on automotive and enterprise computing sectors could drive near-term revenue stability. - Key Risks: The stocks reliance on licensing revenue and high valuation multiples pose risks. Any weakness in semiconductor demand or delays in customer adoption could impact short-term performance. Investors should monitor SMA crossovers and revenue guidance for directional cues.
Additional Sources for AIP Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AIP Stock Overview
Market Cap in USD | 323m |
Sector | Technology |
Industry | Semiconductors |
GiC Sub-Industry | Semiconductors |
IPO / Inception | 2021-10-27 |
AIP Stock Ratings
Growth 5y | -24.4% |
Fundamental | -1.20% |
Dividend | 0.0% |
Rel. Strength Industry | 14.4 |
Analysts | 4.6/5 |
Fair Price Momentum | 6.41 USD |
Fair Price DCF | - |
AIP Dividends
No Dividends PaidAIP Growth Ratios
Growth Correlation 3m | -62.3% |
Growth Correlation 12m | 57.6% |
Growth Correlation 5y | -16% |
CAGR 5y | -22.69% |
CAGR/Max DD 5y | -0.26 |
Sharpe Ratio 12m | -0.06 |
Alpha | -3.04 |
Beta | 2.69 |
Volatility | 64.04% |
Current Volume | 80.7k |
Average Volume 20d | 232.9k |
As of March 15, 2025, the stock is trading at USD 7.63 with a total of 80,681 shares traded.
Over the past week, the price has changed by -3.30%, over one month by -21.82%, over three months by -21.98% and over the past year by +18.66%.
Neither. Based on ValueRay Fundamental Analyses, Arteris is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.20 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AIP as of March 2025 is 6.41. This means that AIP is currently overvalued and has a potential downside of -15.99%.
Arteris has received a consensus analysts rating of 4.60. Therefor, it is recommend to buy AIP.
- Strong Buy: 4
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, AIP Arteris will be worth about 7.6 in March 2026. The stock is currently trading at 7.63. This means that the stock has a potential downside of -0.52%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 13.2 | 73% |
Analysts Target Price | 11.2 | 46.8% |
ValueRay Target Price | 7.6 | -0.5% |